These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35230936)

  • 41. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.
    Chung Y; Lee DH; Lee M; Kim H; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
    Investig Clin Urol; 2020 Mar; 61(2):158-165. PubMed ID: 32158966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is It Safe to Offer Radical Cystectomy to Patients above 85 Years of Age? A Long-Term Follow-Up in a Single-Center Institution.
    Tamalunas A; Volz Y; Schlenker BA; Buchner A; Kretschmer A; Jokisch F; Rodler S; Schulz G; Eismann L; Pfitzinger P; Stief CG; Grimm T
    Urol Int; 2020; 104(11-12):975-981. PubMed ID: 32871580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
    Yanagi M; Hamasaki T; Akatsuka J; Endo Y; Takeda H; Kondo Y
    BMC Urol; 2021 Dec; 21(1):167. PubMed ID: 34856960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of body mass index on the oncological outcomes of patients treated with radical nephroureterectomy for upper tract urothelial carcinoma.
    Dabi Y; El Mrini M; Duquesnes I; Delongchamps NB; Sibony M; Zerbib M; Xylinas E
    World J Urol; 2018 Jan; 36(1):65-71. PubMed ID: 29032451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Ishioka J; Saito K; Kijima T; Nakanishi Y; Yoshida S; Yokoyama M; Matsuoka Y; Numao N; Koga F; Masuda H; Fujii Y; Sakai Y; Arisawa C; Okuno T; Nagahama K; Kamata S; Sakura M; Yonese J; Morimoto S; Noro A; Tsujii T; Kitahara S; Gotoh S; Higashi Y; Kihara K
    BJU Int; 2015 May; 115(5):705-12. PubMed ID: 24612074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review.
    Seisen T; Mari A; Campi R; Peyronnet B; Bensalah K; Rioux-Leclercq N; Pfister C; Gobet F; De La Taille A; Allory Y; Xylinas E; Neuzillet Y; Radulescu C; Descotes JL; Saada-Sebag G; Irani J; Delpech-Debiais C; Bigot P; Eymerit C; Crouzet S; Mege-Lechevallier F; Ruffion A; Decaussin-Petrucci M; Droupy S; Roger P; Durand X; Camparo P; Cussenot O; Compérat E; Rouprêt M
    Eur Urol Focus; 2021 Sep; 7(5):1075-1083. PubMed ID: 33463527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.
    Sharma V; Miest TS; Juvet TS; Toussi A; Packiam V; Chamie K; Matin SF; Boorjian SA; Thompson RH; Frank I; Tollefson MK; Potretzke AM
    J Urol; 2021 Sep; 206(3):558-567. PubMed ID: 33908802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration.
    Soria F; Giordano A; D'Andrea D; Moschini M; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Bensalah K; Mathieu R; Chlosta P; Babjuk M; Glybochko PV; Enikeev DV; Remzi M; Gust K; Gontero P; Shariat SF
    Urol Oncol; 2020 Jun; 38(6):602.e11-602.e19. PubMed ID: 32037197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Ryoo H; Kim J; Kim T; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
    Cancer Res Treat; 2021 Jul; 53(3):795-802. PubMed ID: 33421984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non-urothelial recurrence and other clinical indicators.
    Takahara K; Inamoto T; Komura K; Watsuji T; Azuma H
    Oncol Lett; 2013 Oct; 6(4):1015-1020. PubMed ID: 24137456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraoperative Mitomycin C Bladder Instillation During Radical Nephroureterectomy Is Feasible and Safe.
    Nadler N; Oedorf K; Jensen JB; Azawi N
    Eur Urol Open Sci; 2021 Dec; 34():41-46. PubMed ID: 34934966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
    Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
    Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.
    Baboudjian M; Al-Balushi K; Michel F; Lannes F; Akiki A; Gaillet S; Delaporte V; Ragni E; Toledano H; Karsenty G; Rossi D; Bastide C; Lechevallier E; Boissier R
    World J Urol; 2020 Jan; 38(1):159-165. PubMed ID: 30993427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy.
    Martini A; Lonati C; Montorsi F; Briganti A; Colombo R; Necchi A; Simeone C; Zamboni S; Afferi L; Mattei A; Carando R; Ploussard G; Soria F; Marra G; Rouprêt M; Xylinas E; Pradere B; Abufaraj M; D'Andrea D; Shariat SF; Moschini M
    Clin Genitourin Cancer; 2022 Jun; 20(3):e190-e198. PubMed ID: 35105509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Prognostic Impact of Tumor Location in pT3N0M0 Upper Urinary Tract Urothelial Carcinoma: A Retrospective Cohort Study.
    Chen TS; Chen YT; Wang HJ; Chiang PH; Yang WC; Lee WC; Chuang YC; Cheng YT; Kang CH; Lee WC; Chen CH; Shen YC; Liu YY; Liu HY; Chang YL; Su YL; Huang CC; Luo HL
    Front Oncol; 2022; 12():850874. PubMed ID: 35372015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma.
    Kim TH; Lee CU; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
    Sci Rep; 2021 Apr; 11(1):7828. PubMed ID: 33837237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.